Literature DB >> 22124799

More safety with more energy: survival of electrical storm with 40-J shocks.

D Erkapic1, F Amberger, P Bushoven, J Ehrlich.   

Abstract

We report the first clinical case of ineffective high-voltage therapy with 36 J and subsequent effective therapy with 40 J in a patient with electrical storm who had previously received a high-energy implantable cardioverter defibrillator (ICD, Fortify VR, 1233-40Q St. Jude Medical, Sylmar, CA, USA). Using a combination of high energy and optimized fixed millisecond duration biphasic waveform shock, successful defibrillation could be achieved at 8 J below the programmed maximum energy level.

Entities:  

Mesh:

Year:  2011        PMID: 22124799     DOI: 10.1007/s00399-011-0159-5

Source DB:  PubMed          Journal:  Herzschrittmacherther Elektrophysiol        ISSN: 0938-7412


  7 in total

1.  "Tuned" defibrillation waveforms outperform 50/50% tilt defibrillation waveforms: a randomized multi-center study.

Authors:  Senthil Natarajan; Richard Henthorn; Jefferson Burroughs; Douglas Esberg; Steven Zweibel; Terence Ross; Mark Kroll; Don Gianola; Ashish Oza
Journal:  Pacing Clin Electrophysiol       Date:  2007-01       Impact factor: 1.976

2.  Sudden cardiac death unresponsive to implantable defibrillator therapy: an urgent target for clinicians, industry and government.

Authors:  Kelley P Anderson
Journal:  J Interv Card Electrophysiol       Date:  2005-11       Impact factor: 1.900

3.  Benefit of millisecond waveform durations for patients with high defibrillation thresholds.

Authors:  Russell A Denman; Chirammal Umesan; Paul T Martin; Ross N Forbes; Mark W Kroll; Emma J Anskey; Helen E Burnett
Journal:  Heart Rhythm       Date:  2006-02-28       Impact factor: 6.343

4.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.

Authors:  Gust H Bardy; Kerry L Lee; Daniel B Mark; Jeanne E Poole; Douglas L Packer; Robin Boineau; Michael Domanski; Charles Troutman; Jill Anderson; George Johnson; Steven E McNulty; Nancy Clapp-Channing; Linda D Davidson-Ray; Elizabeth S Fraulo; Daniel P Fishbein; Richard M Luceri; John H Ip
Journal:  N Engl J Med       Date:  2005-01-20       Impact factor: 91.245

5.  A randomized prospective study of single coil versus dual coil defibrillation in patients with ventricular arrhythmias undergoing implantable cardioverter defibrillator therapy.

Authors:  C Aldo Rinaldi; Ron D B Simon; Peter Geelen; Sven Reek; Artur Baszko; Martin Kuehl; Jaswinder S Gill
Journal:  Pacing Clin Electrophysiol       Date:  2003-08       Impact factor: 1.976

6.  Arrhythmic death in implantable cardioverter defibrillator patients: a long-term study over a 10 year implantation period.

Authors:  Gabor Z Duray; Joern Schmitt; Sergio Richter; Carsten W Israel; Stefan H Hohnloser
Journal:  Europace       Date:  2009-09-29       Impact factor: 5.214

7.  Intraoperative defibrillation threshold testing during implantable cardioverter-defibrillator insertion: do we really need it?

Authors:  Valeria Calvi; Daniela Dugo; Davide Capodanno; Rocco Arancio; Angelo Di Grazia; Claudio Liotta; Euglena Puzzangara; Antonio Ragusa; Alberto Arestia; Corrado Tamburino
Journal:  Am Heart J       Date:  2010-01       Impact factor: 4.749

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.